CLINICAL_TRIALS
trial_result
· 2011-02-07
Clinical Trial Update: Study Evaluating Refacto For Pharmacovigilance
Summary
A completed pharmacovigilance study evaluating Refacto for Hemophilia A has posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Hemophilia A | Status: COMPLETED | Results posted: 2011-02-07